ABBV
AbbViestockResearch ABBV
ABBV · 90-day price history
Prediction models
All predictions →Trend follower
Horizon: 1 week
How this worksHide explanation
Compares a 10-day vs 50-day moving average. When the short-term average rises above the long-term average, the trend is up.
Not financial advice. Past accuracy does not guarantee future results.
Momentum
Horizon: 1 week
How this worksHide explanation
Uses RSI (a gauge of recent buying/selling intensity) and 5-day rate-of-change to judge whether the stock has been pushed too far in one direction.
Not financial advice. Past accuracy does not guarantee future results.
Statistical trend
Horizon: 1 month
How this worksHide explanation
Fits a trend line through the last 60 days of prices and measures how far the current price has strayed from it.
Not financial advice. Past accuracy does not guarantee future results.
Multi-factor + news
Horizon: 1 week
Accuracy reflects technical signals only. News sentiment is live.
How this worksHide explanation
Combines trend (25%), momentum (25%), volume (15%), and AI-analysed news sentiment (35%) from your trusted sources into one score.
Not financial advice. Past accuracy does not guarantee future results.
Bull / Bear thesis
AI analysisStrong cancer drug efficacy confirmed
Epcoritamab EPCORE DLBCL-2 shows 51% reduction in disease progression/death risk versus standard treatment
YahooOncology pipeline delivering clinically meaningful results
Drug works well in difficult-to-treat DLBCL patients with steroid-free disease control
YahooStock near record highs despite flat trading
Closed near all-time highs showing long-term investor conviction despite small daily move
Price actionFlat move despite positive trial data
Down 0.03% despite positive epcoritamab Phase 3 results, suggesting market already priced it in
Price actionSuccess already built into valuation
Trial results positive but stock shows no bounce, indicating high bar already set
Price actionSkyrizi and Rinvoq must sustain growth
Guidance raise already relies on these drugs maintaining momentum
YahooAI-generated from recent news and price action. Not financial advice. Educational only.
Seasonality
~5y of historyAvg return by month · %
This month historically: +0.56% on average, up 60% of 5 years.
Avg return by weekday · %
Historical pattern only — seasonality is not a prediction and often breaks.
Recent news
Yahoo · Oct 15
Analyst argues market hasn't fully priced successful oncology trial data, suggesting upside potential.
Yahoo · Oct 15
Epcoritamab efficacy validates ABBV's cancer strategy and could expand addressable market.
Yahoo · Oct 15
ABBV near record high riding healthcare sector strength from rotation out of AI stocks.
AI research companion
AI Research Companion
Loading…